(Q44865776)

6 December 2017

Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents (English)

1 reference

6 December 2017

1 reference

Campylobacter pylori

1 reference

C A McNulty

1

1 reference

PubMed ID

3141174

6 December 2017

J C Dent

series ordinal

2

1 reference

6 December 2017

1 August 1988

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

6 December 2017

1 reference

6 December 2017

7

1 reference

6 December 2017

4

1 reference

6 December 2017

566-569

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01962617

6 December 2017

0 references

cites work

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

1 reference

https://api.crossref.org/works/10.1007%2FBF01962617

Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962617

Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962617

Oral bioavailability of the monobactam aztreonam (SQ 26,776) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962617

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962617

In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962617

Chemotherapeutic properties of prominent nitrofurans

21 January 2018

1 reference

12 December 2020

Bismuth/ofloxacin combination for duodenal ulcer

1 reference

12 December 2020

Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis

1 reference

12 December 2020

Inocula for antimicrobial sensitivity testing: a critical review

1 reference

12 December 2020

Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study

1 reference

12 December 2020

Gastrointestinal absorption and metabolism of two35S-labelled ampicillin esters

1 reference

12 December 2020

The in vitro and in vivo activity of ciprofloxacin

1 reference

12 December 2020

The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

1 reference

12 December 2020

Antibacterial activity of a monocyclic beta-lactam SQ 26,776.

1 reference

12 December 2020

In-vitro sensitivity of Campylobacter pyloridis to furazolidone

1 reference

12 December 2020

Treatment failure of ofloxacin in Campylobacter pylori infection

1 reference

12 December 2020

The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid

1 reference

12 December 2020

Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01962617

1 reference

6 December 2017

1 reference

PubMed ID

3141174